Currently, treatment approaches are based only on adult data, and problems exist in extrapolating these data to a pediatric population. PubMed, Curr Rheumatol Rep, 2015 Mar;17(3):491. (Also see Juvenile Scleroderma)
This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.